Skip to main navigation Skip to search Skip to main content

Paralytic Peptide For Use In Neuromuscular Therapy

Research output: Patent

Abstract

The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species 'Blarina' as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
Original languageEnglish
Patent number7119168
Publication statusPublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cell Neurochemistry

Fingerprint

Dive into the research topics of 'Paralytic Peptide For Use In Neuromuscular Therapy'. Together they form a unique fingerprint.

Cite this